Article
Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature.
American journal of medical genetics. Part A - 1 Apr 2016
Canton Ana Pinheiro Machado, Nishi Mirian Yumie, Furuya Tatiane Katsue, Roela Rosimeire Aparecida, Jorge Alexander Augusto Lima
Abstract excerpt
The 9p trisomy syndrome is a rare condition, clinically characterized by a wide range of dysmorphic features, intellectual disability, and, in most patients, by short stature. Recombinant human growth hormone (rhGH) therapy is still controversial in syndromic disorders, the reason for which it is not currently indicated. Here we report a 7-year-old boy with 9p trisomy syndrome and marked short stature. Results of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
